Global Veterinary Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, The global Veterinary Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.
Veterinary Vaccine segment by Company
1. To analyze and research the global Veterinary Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Veterinary Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Veterinary Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Veterinary Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Veterinary Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Vaccine industry.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Veterinary Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, The global Veterinary Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.
Veterinary Vaccine segment by Company
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- BioTestLab
- RVSRI
- Medion
- Live Attenuated Vaccines
- Inactivated Vaccines
- Others
- Livestock
- Swine
- Chicken
- Dog & Cat
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Veterinary Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Veterinary Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Veterinary Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Veterinary Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Veterinary Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Vaccine industry.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Veterinary Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Veterinary Vaccine Sales Value (2019-2030)
1.2.2 Global Veterinary Vaccine Sales Volume (2019-2030)
1.2.3 Global Veterinary Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 VETERINARY VACCINE MARKET DYNAMICS
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 VETERINARY VACCINE MARKET BY COMPANY
3.1 Global Veterinary Vaccine Company Revenue Ranking in 2023
3.2 Global Veterinary Vaccine Revenue by Company (2019-2024)
3.3 Global Veterinary Vaccine Sales Volume by Company (2019-2024)
3.4 Global Veterinary Vaccine Average Price by Company (2019-2024)
3.5 Global Veterinary Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Veterinary Vaccine Company Manufacturing Base & Headquarters
3.7 Global Veterinary Vaccine Company, Product Type & Application
3.8 Global Veterinary Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Veterinary Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 VETERINARY VACCINE MARKET BY TYPE
4.1 Veterinary Vaccine Type Introduction
4.1.1 Live Attenuated Vaccines
4.1.2 Inactivated Vaccines
4.1.3 Others
4.2 Global Veterinary Vaccine Sales Volume by Type
4.2.1 Global Veterinary Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Veterinary Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Veterinary Vaccine Sales Value by Type
4.3.1 Global Veterinary Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Veterinary Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Veterinary Vaccine Sales Value Share by Type (2019-2030)
5 VETERINARY VACCINE MARKET BY APPLICATION
5.1 Veterinary Vaccine Application Introduction
5.1.1 Livestock
5.1.2 Swine
5.1.3 Chicken
5.1.4 Dog & Cat
5.1.5 Others
5.2 Global Veterinary Vaccine Sales Volume by Application
5.2.1 Global Veterinary Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Veterinary Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Veterinary Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Veterinary Vaccine Sales Value by Application
5.3.1 Global Veterinary Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Veterinary Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Veterinary Vaccine Sales Value Share by Application (2019-2030)
6 VETERINARY VACCINE MARKET BY REGION
6.1 Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Veterinary Vaccine Sales by Region (2019-2030)
6.2.1 Global Veterinary Vaccine Sales by Region: 2019-2024
6.2.2 Global Veterinary Vaccine Sales by Region (2025-2030)
6.3 Global Veterinary Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Veterinary Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Veterinary Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Veterinary Vaccine Sales Value by Region (2025-2030)
6.5 Global Veterinary Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Veterinary Vaccine Sales Value (2019-2030)
6.6.2 North America Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Veterinary Vaccine Sales Value (2019-2030)
6.7.2 Europe Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Veterinary Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Veterinary Vaccine Sales Value (2019-2030)
6.9.2 Latin America Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Veterinary Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
7 VETERINARY VACCINE MARKET BY COUNTRY
7.1 Global Veterinary Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Veterinary Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Veterinary Vaccine Sales by Country (2019-2030)
7.3.1 Global Veterinary Vaccine Sales by Country (2019-2024)
7.3.2 Global Veterinary Vaccine Sales by Country (2025-2030)
7.4 Global Veterinary Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Veterinary Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Veterinary Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Merck Veterinary Vaccine Product Portfolio
8.1.5 Merck Recent Developments
8.2 Zoetis
8.2.1 Zoetis Comapny Information
8.2.2 Zoetis Business Overview
8.2.3 Zoetis Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 Zoetis Veterinary Vaccine Product Portfolio
8.2.5 Zoetis Recent Developments
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Comapny Information
8.3.2 Boehringer Ingelheim Business Overview
8.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
8.3.5 Boehringer Ingelheim Recent Developments
8.4 Ceva
8.4.1 Ceva Comapny Information
8.4.2 Ceva Business Overview
8.4.3 Ceva Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Ceva Veterinary Vaccine Product Portfolio
8.4.5 Ceva Recent Developments
8.5 CAHIC
8.5.1 CAHIC Comapny Information
8.5.2 CAHIC Business Overview
8.5.3 CAHIC Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 CAHIC Veterinary Vaccine Product Portfolio
8.5.5 CAHIC Recent Developments
8.6 HVRI
8.6.1 HVRI Comapny Information
8.6.2 HVRI Business Overview
8.6.3 HVRI Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 HVRI Veterinary Vaccine Product Portfolio
8.6.5 HVRI Recent Developments
8.7 Ringpu Biology
8.7.1 Ringpu Biology Comapny Information
8.7.2 Ringpu Biology Business Overview
8.7.3 Ringpu Biology Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
8.7.5 Ringpu Biology Recent Developments
8.8 Yebio
8.8.1 Yebio Comapny Information
8.8.2 Yebio Business Overview
8.8.3 Yebio Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 Yebio Veterinary Vaccine Product Portfolio
8.8.5 Yebio Recent Developments
8.9 DHN
8.9.1 DHN Comapny Information
8.9.2 DHN Business Overview
8.9.3 DHN Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.9.4 DHN Veterinary Vaccine Product Portfolio
8.9.5 DHN Recent Developments
8.10 WINSUN
8.10.1 WINSUN Comapny Information
8.10.2 WINSUN Business Overview
8.10.3 WINSUN Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.10.4 WINSUN Veterinary Vaccine Product Portfolio
8.10.5 WINSUN Recent Developments
8.11 Elanco
8.11.1 Elanco Comapny Information
8.11.2 Elanco Business Overview
8.11.3 Elanco Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.11.4 Elanco Veterinary Vaccine Product Portfolio
8.11.5 Elanco Recent Developments
8.12 Virbac
8.12.1 Virbac Comapny Information
8.12.2 Virbac Business Overview
8.12.3 Virbac Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.12.4 Virbac Veterinary Vaccine Product Portfolio
8.12.5 Virbac Recent Developments
8.13 Jinyu Bio-Technology
8.13.1 Jinyu Bio-Technology Comapny Information
8.13.2 Jinyu Bio-Technology Business Overview
8.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
8.13.5 Jinyu Bio-Technology Recent Developments
8.14 ChengDu Tecbond
8.14.1 ChengDu Tecbond Comapny Information
8.14.2 ChengDu Tecbond Business Overview
8.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
8.14.5 ChengDu Tecbond Recent Developments
8.15 CAVAC
8.15.1 CAVAC Comapny Information
8.15.2 CAVAC Business Overview
8.15.3 CAVAC Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.15.4 CAVAC Veterinary Vaccine Product Portfolio
8.15.5 CAVAC Recent Developments
8.16 Kyoto Biken Laboratories
8.16.1 Kyoto Biken Laboratories Comapny Information
8.16.2 Kyoto Biken Laboratories Business Overview
8.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
8.16.5 Kyoto Biken Laboratories Recent Developments
8.17 FATRO
8.17.1 FATRO Comapny Information
8.17.2 FATRO Business Overview
8.17.3 FATRO Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.17.4 FATRO Veterinary Vaccine Product Portfolio
8.17.5 FATRO Recent Developments
8.18 Vaksindo
8.18.1 Vaksindo Comapny Information
8.18.2 Vaksindo Business Overview
8.18.3 Vaksindo Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.18.4 Vaksindo Veterinary Vaccine Product Portfolio
8.18.5 Vaksindo Recent Developments
8.19 Bio-Labs
8.19.1 Bio-Labs Comapny Information
8.19.2 Bio-Labs Business Overview
8.19.3 Bio-Labs Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
8.19.5 Bio-Labs Recent Developments
8.20 Avimex Animal Health
8.20.1 Avimex Animal Health Comapny Information
8.20.2 Avimex Animal Health Business Overview
8.20.3 Avimex Animal Health Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
8.20.5 Avimex Animal Health Recent Developments
8.21 MEVAC
8.21.1 MEVAC Comapny Information
8.21.2 MEVAC Business Overview
8.21.3 MEVAC Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.21.4 MEVAC Veterinary Vaccine Product Portfolio
8.21.5 MEVAC Recent Developments
8.22 Biovac
8.22.1 Biovac Comapny Information
8.22.2 Biovac Business Overview
8.22.3 Biovac Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.22.4 Biovac Veterinary Vaccine Product Portfolio
8.22.5 Biovac Recent Developments
8.23 Atafen
8.23.1 Atafen Comapny Information
8.23.2 Atafen Business Overview
8.23.3 Atafen Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.23.4 Atafen Veterinary Vaccine Product Portfolio
8.23.5 Atafen Recent Developments
8.24 Dyntec
8.24.1 Dyntec Comapny Information
8.24.2 Dyntec Business Overview
8.24.3 Dyntec Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.24.4 Dyntec Veterinary Vaccine Product Portfolio
8.24.5 Dyntec Recent Developments
8.25 BioTestLab
8.25.1 BioTestLab Comapny Information
8.25.2 BioTestLab Business Overview
8.25.3 BioTestLab Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.25.4 BioTestLab Veterinary Vaccine Product Portfolio
8.25.5 BioTestLab Recent Developments
8.26 RVSRI
8.26.1 RVSRI Comapny Information
8.26.2 RVSRI Business Overview
8.26.3 RVSRI Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.26.4 RVSRI Veterinary Vaccine Product Portfolio
8.26.5 RVSRI Recent Developments
8.27 Medion
8.27.1 Medion Comapny Information
8.27.2 Medion Business Overview
8.27.3 Medion Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.27.4 Medion Veterinary Vaccine Product Portfolio
8.27.5 Medion Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Veterinary Vaccine Value Chain Analysis
9.1.1 Veterinary Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Veterinary Vaccine Sales Mode & Process
9.2 Veterinary Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Veterinary Vaccine Distributors
9.2.3 Veterinary Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Veterinary Vaccine Sales Value (2019-2030)
1.2.2 Global Veterinary Vaccine Sales Volume (2019-2030)
1.2.3 Global Veterinary Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 VETERINARY VACCINE MARKET DYNAMICS
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 VETERINARY VACCINE MARKET BY COMPANY
3.1 Global Veterinary Vaccine Company Revenue Ranking in 2023
3.2 Global Veterinary Vaccine Revenue by Company (2019-2024)
3.3 Global Veterinary Vaccine Sales Volume by Company (2019-2024)
3.4 Global Veterinary Vaccine Average Price by Company (2019-2024)
3.5 Global Veterinary Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Veterinary Vaccine Company Manufacturing Base & Headquarters
3.7 Global Veterinary Vaccine Company, Product Type & Application
3.8 Global Veterinary Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Veterinary Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 VETERINARY VACCINE MARKET BY TYPE
4.1 Veterinary Vaccine Type Introduction
4.1.1 Live Attenuated Vaccines
4.1.2 Inactivated Vaccines
4.1.3 Others
4.2 Global Veterinary Vaccine Sales Volume by Type
4.2.1 Global Veterinary Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Veterinary Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Veterinary Vaccine Sales Value by Type
4.3.1 Global Veterinary Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Veterinary Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Veterinary Vaccine Sales Value Share by Type (2019-2030)
5 VETERINARY VACCINE MARKET BY APPLICATION
5.1 Veterinary Vaccine Application Introduction
5.1.1 Livestock
5.1.2 Swine
5.1.3 Chicken
5.1.4 Dog & Cat
5.1.5 Others
5.2 Global Veterinary Vaccine Sales Volume by Application
5.2.1 Global Veterinary Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Veterinary Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Veterinary Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Veterinary Vaccine Sales Value by Application
5.3.1 Global Veterinary Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Veterinary Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Veterinary Vaccine Sales Value Share by Application (2019-2030)
6 VETERINARY VACCINE MARKET BY REGION
6.1 Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Veterinary Vaccine Sales by Region (2019-2030)
6.2.1 Global Veterinary Vaccine Sales by Region: 2019-2024
6.2.2 Global Veterinary Vaccine Sales by Region (2025-2030)
6.3 Global Veterinary Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Veterinary Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Veterinary Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Veterinary Vaccine Sales Value by Region (2025-2030)
6.5 Global Veterinary Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Veterinary Vaccine Sales Value (2019-2030)
6.6.2 North America Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Veterinary Vaccine Sales Value (2019-2030)
6.7.2 Europe Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Veterinary Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Veterinary Vaccine Sales Value (2019-2030)
6.9.2 Latin America Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Veterinary Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Veterinary Vaccine Sales Value Share by Country, 2023 VS 2030
7 VETERINARY VACCINE MARKET BY COUNTRY
7.1 Global Veterinary Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Veterinary Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Veterinary Vaccine Sales by Country (2019-2030)
7.3.1 Global Veterinary Vaccine Sales by Country (2019-2024)
7.3.2 Global Veterinary Vaccine Sales by Country (2025-2030)
7.4 Global Veterinary Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Veterinary Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Veterinary Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Veterinary Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Veterinary Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Veterinary Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Merck Veterinary Vaccine Product Portfolio
8.1.5 Merck Recent Developments
8.2 Zoetis
8.2.1 Zoetis Comapny Information
8.2.2 Zoetis Business Overview
8.2.3 Zoetis Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 Zoetis Veterinary Vaccine Product Portfolio
8.2.5 Zoetis Recent Developments
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Comapny Information
8.3.2 Boehringer Ingelheim Business Overview
8.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
8.3.5 Boehringer Ingelheim Recent Developments
8.4 Ceva
8.4.1 Ceva Comapny Information
8.4.2 Ceva Business Overview
8.4.3 Ceva Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Ceva Veterinary Vaccine Product Portfolio
8.4.5 Ceva Recent Developments
8.5 CAHIC
8.5.1 CAHIC Comapny Information
8.5.2 CAHIC Business Overview
8.5.3 CAHIC Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 CAHIC Veterinary Vaccine Product Portfolio
8.5.5 CAHIC Recent Developments
8.6 HVRI
8.6.1 HVRI Comapny Information
8.6.2 HVRI Business Overview
8.6.3 HVRI Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 HVRI Veterinary Vaccine Product Portfolio
8.6.5 HVRI Recent Developments
8.7 Ringpu Biology
8.7.1 Ringpu Biology Comapny Information
8.7.2 Ringpu Biology Business Overview
8.7.3 Ringpu Biology Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
8.7.5 Ringpu Biology Recent Developments
8.8 Yebio
8.8.1 Yebio Comapny Information
8.8.2 Yebio Business Overview
8.8.3 Yebio Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 Yebio Veterinary Vaccine Product Portfolio
8.8.5 Yebio Recent Developments
8.9 DHN
8.9.1 DHN Comapny Information
8.9.2 DHN Business Overview
8.9.3 DHN Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.9.4 DHN Veterinary Vaccine Product Portfolio
8.9.5 DHN Recent Developments
8.10 WINSUN
8.10.1 WINSUN Comapny Information
8.10.2 WINSUN Business Overview
8.10.3 WINSUN Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.10.4 WINSUN Veterinary Vaccine Product Portfolio
8.10.5 WINSUN Recent Developments
8.11 Elanco
8.11.1 Elanco Comapny Information
8.11.2 Elanco Business Overview
8.11.3 Elanco Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.11.4 Elanco Veterinary Vaccine Product Portfolio
8.11.5 Elanco Recent Developments
8.12 Virbac
8.12.1 Virbac Comapny Information
8.12.2 Virbac Business Overview
8.12.3 Virbac Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.12.4 Virbac Veterinary Vaccine Product Portfolio
8.12.5 Virbac Recent Developments
8.13 Jinyu Bio-Technology
8.13.1 Jinyu Bio-Technology Comapny Information
8.13.2 Jinyu Bio-Technology Business Overview
8.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
8.13.5 Jinyu Bio-Technology Recent Developments
8.14 ChengDu Tecbond
8.14.1 ChengDu Tecbond Comapny Information
8.14.2 ChengDu Tecbond Business Overview
8.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
8.14.5 ChengDu Tecbond Recent Developments
8.15 CAVAC
8.15.1 CAVAC Comapny Information
8.15.2 CAVAC Business Overview
8.15.3 CAVAC Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.15.4 CAVAC Veterinary Vaccine Product Portfolio
8.15.5 CAVAC Recent Developments
8.16 Kyoto Biken Laboratories
8.16.1 Kyoto Biken Laboratories Comapny Information
8.16.2 Kyoto Biken Laboratories Business Overview
8.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
8.16.5 Kyoto Biken Laboratories Recent Developments
8.17 FATRO
8.17.1 FATRO Comapny Information
8.17.2 FATRO Business Overview
8.17.3 FATRO Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.17.4 FATRO Veterinary Vaccine Product Portfolio
8.17.5 FATRO Recent Developments
8.18 Vaksindo
8.18.1 Vaksindo Comapny Information
8.18.2 Vaksindo Business Overview
8.18.3 Vaksindo Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.18.4 Vaksindo Veterinary Vaccine Product Portfolio
8.18.5 Vaksindo Recent Developments
8.19 Bio-Labs
8.19.1 Bio-Labs Comapny Information
8.19.2 Bio-Labs Business Overview
8.19.3 Bio-Labs Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
8.19.5 Bio-Labs Recent Developments
8.20 Avimex Animal Health
8.20.1 Avimex Animal Health Comapny Information
8.20.2 Avimex Animal Health Business Overview
8.20.3 Avimex Animal Health Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
8.20.5 Avimex Animal Health Recent Developments
8.21 MEVAC
8.21.1 MEVAC Comapny Information
8.21.2 MEVAC Business Overview
8.21.3 MEVAC Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.21.4 MEVAC Veterinary Vaccine Product Portfolio
8.21.5 MEVAC Recent Developments
8.22 Biovac
8.22.1 Biovac Comapny Information
8.22.2 Biovac Business Overview
8.22.3 Biovac Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.22.4 Biovac Veterinary Vaccine Product Portfolio
8.22.5 Biovac Recent Developments
8.23 Atafen
8.23.1 Atafen Comapny Information
8.23.2 Atafen Business Overview
8.23.3 Atafen Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.23.4 Atafen Veterinary Vaccine Product Portfolio
8.23.5 Atafen Recent Developments
8.24 Dyntec
8.24.1 Dyntec Comapny Information
8.24.2 Dyntec Business Overview
8.24.3 Dyntec Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.24.4 Dyntec Veterinary Vaccine Product Portfolio
8.24.5 Dyntec Recent Developments
8.25 BioTestLab
8.25.1 BioTestLab Comapny Information
8.25.2 BioTestLab Business Overview
8.25.3 BioTestLab Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.25.4 BioTestLab Veterinary Vaccine Product Portfolio
8.25.5 BioTestLab Recent Developments
8.26 RVSRI
8.26.1 RVSRI Comapny Information
8.26.2 RVSRI Business Overview
8.26.3 RVSRI Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.26.4 RVSRI Veterinary Vaccine Product Portfolio
8.26.5 RVSRI Recent Developments
8.27 Medion
8.27.1 Medion Comapny Information
8.27.2 Medion Business Overview
8.27.3 Medion Veterinary Vaccine Sales, Value and Gross Margin (2019-2024)
8.27.4 Medion Veterinary Vaccine Product Portfolio
8.27.5 Medion Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Veterinary Vaccine Value Chain Analysis
9.1.1 Veterinary Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Veterinary Vaccine Sales Mode & Process
9.2 Veterinary Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Veterinary Vaccine Distributors
9.2.3 Veterinary Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Veterinary Vaccine Industry Trends
Table 2. Veterinary Vaccine Industry Drivers
Table 3. Veterinary Vaccine Industry Opportunities and Challenges
Table 4. Veterinary Vaccine Industry Restraints
Table 5. Global Veterinary Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Veterinary Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Veterinary Vaccine Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Veterinary Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Veterinary Vaccine Average Price (USD/Doses) of Company (2019-2024)
Table 10. Global Veterinary Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Veterinary Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Veterinary Vaccine Company, Product Type & Application
Table 13. Global Veterinary Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Live Attenuated Vaccines
Table 18. Major Companies of Inactivated Vaccines
Table 19. Major Companies of Others
Table 20. Global Veterinary Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 21. Global Veterinary Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 22. Global Veterinary Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 23. Global Veterinary Vaccine Sales Volume Share by Type (2019-2024)
Table 24. Global Veterinary Vaccine Sales Volume Share by Type (2025-2030)
Table 25. Global Veterinary Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Veterinary Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 27. Global Veterinary Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 28. Global Veterinary Vaccine Sales Value Share by Type (2019-2024)
Table 29. Global Veterinary Vaccine Sales Value Share by Type (2025-2030)
Table 30. Major Companies of Livestock
Table 31. Major Companies of Swine
Table 32. Major Companies of Chicken
Table 33. Major Companies of Dog & Cat
Table 34. Major Companies of Others
Table 35. Global Veterinary Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 36. Global Veterinary Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 37. Global Veterinary Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 38. Global Veterinary Vaccine Sales Volume Share by Application (2019-2024)
Table 39. Global Veterinary Vaccine Sales Volume Share by Application (2025-2030)
Table 40. Global Veterinary Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Veterinary Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 42. Global Veterinary Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 43. Global Veterinary Vaccine Sales Value Share by Application (2019-2024)
Table 44. Global Veterinary Vaccine Sales Value Share by Application (2025-2030)
Table 45. Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 46. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 47. Global Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 48. Global Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
Table 49. Global Veterinary Vaccine Sales Market Share by Region (2025-2030)
Table 50. Global Veterinary Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 51. Global Veterinary Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 52. Global Veterinary Vaccine Sales Value Share by Region (2019-2024)
Table 53. Global Veterinary Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 54. Global Veterinary Vaccine Sales Value Share by Region (2025-2030)
Table 55. Global Veterinary Vaccine Market Average Price (USD/Doses) by Region (2019-2024)
Table 56. Global Veterinary Vaccine Market Average Price (USD/Doses) by Region (2025-2030)
Table 57. Global Veterinary Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 58. Global Veterinary Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 60. Global Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 61. Global Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 62. Global Veterinary Vaccine Sales Market Share by Country (2025-2030)
Table 63. Global Veterinary Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 64. Global Veterinary Vaccine Sales Value Market Share by Country (2019-2024)
Table 65. Global Veterinary Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 66. Global Veterinary Vaccine Sales Value Market Share by Country (2025-2030)
Table 67. Merck Company Information
Table 68. Merck Business Overview
Table 69. Merck Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 70. Merck Veterinary Vaccine Product Portfolio
Table 71. Merck Recent Development
Table 72. Zoetis Company Information
Table 73. Zoetis Business Overview
Table 74. Zoetis Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 75. Zoetis Veterinary Vaccine Product Portfolio
Table 76. Zoetis Recent Development
Table 77. Boehringer Ingelheim Company Information
Table 78. Boehringer Ingelheim Business Overview
Table 79. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 80. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 81. Boehringer Ingelheim Recent Development
Table 82. Ceva Company Information
Table 83. Ceva Business Overview
Table 84. Ceva Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 85. Ceva Veterinary Vaccine Product Portfolio
Table 86. Ceva Recent Development
Table 87. CAHIC Company Information
Table 88. CAHIC Business Overview
Table 89. CAHIC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 90. CAHIC Veterinary Vaccine Product Portfolio
Table 91. CAHIC Recent Development
Table 92. HVRI Company Information
Table 93. HVRI Business Overview
Table 94. HVRI Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 95. HVRI Veterinary Vaccine Product Portfolio
Table 96. HVRI Recent Development
Table 97. Ringpu Biology Company Information
Table 98. Ringpu Biology Business Overview
Table 99. Ringpu Biology Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 100. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 101. Ringpu Biology Recent Development
Table 102. Yebio Company Information
Table 103. Yebio Business Overview
Table 104. Yebio Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 105. Yebio Veterinary Vaccine Product Portfolio
Table 106. Yebio Recent Development
Table 107. DHN Company Information
Table 108. DHN Business Overview
Table 109. DHN Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 110. DHN Veterinary Vaccine Product Portfolio
Table 111. DHN Recent Development
Table 112. WINSUN Company Information
Table 113. WINSUN Business Overview
Table 114. WINSUN Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 115. WINSUN Veterinary Vaccine Product Portfolio
Table 116. WINSUN Recent Development
Table 117. Elanco Company Information
Table 118. Elanco Business Overview
Table 119. Elanco Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 120. Elanco Veterinary Vaccine Product Portfolio
Table 121. Elanco Recent Development
Table 122. Virbac Company Information
Table 123. Virbac Business Overview
Table 124. Virbac Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 125. Virbac Veterinary Vaccine Product Portfolio
Table 126. Virbac Recent Development
Table 127. Jinyu Bio-Technology Company Information
Table 128. Jinyu Bio-Technology Business Overview
Table 129. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 130. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 131. Jinyu Bio-Technology Recent Development
Table 132. ChengDu Tecbond Company Information
Table 133. ChengDu Tecbond Business Overview
Table 134. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 135. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 136. ChengDu Tecbond Recent Development
Table 137. CAVAC Company Information
Table 138. CAVAC Business Overview
Table 139. CAVAC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 140. CAVAC Veterinary Vaccine Product Portfolio
Table 141. CAVAC Recent Development
Table 142. Kyoto Biken Laboratories Company Information
Table 143. Kyoto Biken Laboratories Business Overview
Table 144. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 145. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 146. Kyoto Biken Laboratories Recent Development
Table 147. FATRO Company Information
Table 148. FATRO Business Overview
Table 149. FATRO Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 150. FATRO Veterinary Vaccine Product Portfolio
Table 151. FATRO Recent Development
Table 152. Vaksindo Company Information
Table 153. Vaksindo Business Overview
Table 154. Vaksindo Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 155. Vaksindo Veterinary Vaccine Product Portfolio
Table 156. Vaksindo Recent Development
Table 157. Bio-Labs Company Information
Table 158. Bio-Labs Business Overview
Table 159. Bio-Labs Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 160. Bio-Labs Veterinary Vaccine Product Portfolio
Table 161. Bio-Labs Recent Development
Table 162. Avimex Animal Health Company Information
Table 163. Avimex Animal Health Business Overview
Table 164. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 165. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 166. Avimex Animal Health Recent Development
Table 167. MEVAC Company Information
Table 168. MEVAC Business Overview
Table 169. MEVAC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 170. MEVAC Veterinary Vaccine Product Portfolio
Table 171. MEVAC Recent Development
Table 172. Biovac Company Information
Table 173. Biovac Business Overview
Table 174. Biovac Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 175. Biovac Veterinary Vaccine Product Portfolio
Table 176. Biovac Recent Development
Table 177. Atafen Company Information
Table 178. Atafen Business Overview
Table 179. Atafen Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 180. Atafen Veterinary Vaccine Product Portfolio
Table 181. Atafen Recent Development
Table 182. Dyntec Company Information
Table 183. Dyntec Business Overview
Table 184. Dyntec Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 185. Dyntec Veterinary Vaccine Product Portfolio
Table 186. Dyntec Recent Development
Table 187. BioTestLab Company Information
Table 188. BioTestLab Business Overview
Table 189. BioTestLab Veterinary Vaccine Sales (M Doses
Table 1. Veterinary Vaccine Industry Trends
Table 2. Veterinary Vaccine Industry Drivers
Table 3. Veterinary Vaccine Industry Opportunities and Challenges
Table 4. Veterinary Vaccine Industry Restraints
Table 5. Global Veterinary Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Veterinary Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Veterinary Vaccine Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Veterinary Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Veterinary Vaccine Average Price (USD/Doses) of Company (2019-2024)
Table 10. Global Veterinary Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Veterinary Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Veterinary Vaccine Company, Product Type & Application
Table 13. Global Veterinary Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Live Attenuated Vaccines
Table 18. Major Companies of Inactivated Vaccines
Table 19. Major Companies of Others
Table 20. Global Veterinary Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 21. Global Veterinary Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 22. Global Veterinary Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 23. Global Veterinary Vaccine Sales Volume Share by Type (2019-2024)
Table 24. Global Veterinary Vaccine Sales Volume Share by Type (2025-2030)
Table 25. Global Veterinary Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Veterinary Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 27. Global Veterinary Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 28. Global Veterinary Vaccine Sales Value Share by Type (2019-2024)
Table 29. Global Veterinary Vaccine Sales Value Share by Type (2025-2030)
Table 30. Major Companies of Livestock
Table 31. Major Companies of Swine
Table 32. Major Companies of Chicken
Table 33. Major Companies of Dog & Cat
Table 34. Major Companies of Others
Table 35. Global Veterinary Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 36. Global Veterinary Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 37. Global Veterinary Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 38. Global Veterinary Vaccine Sales Volume Share by Application (2019-2024)
Table 39. Global Veterinary Vaccine Sales Volume Share by Application (2025-2030)
Table 40. Global Veterinary Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Veterinary Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 42. Global Veterinary Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 43. Global Veterinary Vaccine Sales Value Share by Application (2019-2024)
Table 44. Global Veterinary Vaccine Sales Value Share by Application (2025-2030)
Table 45. Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 46. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 47. Global Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 48. Global Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
Table 49. Global Veterinary Vaccine Sales Market Share by Region (2025-2030)
Table 50. Global Veterinary Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 51. Global Veterinary Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 52. Global Veterinary Vaccine Sales Value Share by Region (2019-2024)
Table 53. Global Veterinary Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 54. Global Veterinary Vaccine Sales Value Share by Region (2025-2030)
Table 55. Global Veterinary Vaccine Market Average Price (USD/Doses) by Region (2019-2024)
Table 56. Global Veterinary Vaccine Market Average Price (USD/Doses) by Region (2025-2030)
Table 57. Global Veterinary Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 58. Global Veterinary Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 60. Global Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 61. Global Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 62. Global Veterinary Vaccine Sales Market Share by Country (2025-2030)
Table 63. Global Veterinary Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 64. Global Veterinary Vaccine Sales Value Market Share by Country (2019-2024)
Table 65. Global Veterinary Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 66. Global Veterinary Vaccine Sales Value Market Share by Country (2025-2030)
Table 67. Merck Company Information
Table 68. Merck Business Overview
Table 69. Merck Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 70. Merck Veterinary Vaccine Product Portfolio
Table 71. Merck Recent Development
Table 72. Zoetis Company Information
Table 73. Zoetis Business Overview
Table 74. Zoetis Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 75. Zoetis Veterinary Vaccine Product Portfolio
Table 76. Zoetis Recent Development
Table 77. Boehringer Ingelheim Company Information
Table 78. Boehringer Ingelheim Business Overview
Table 79. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 80. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 81. Boehringer Ingelheim Recent Development
Table 82. Ceva Company Information
Table 83. Ceva Business Overview
Table 84. Ceva Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 85. Ceva Veterinary Vaccine Product Portfolio
Table 86. Ceva Recent Development
Table 87. CAHIC Company Information
Table 88. CAHIC Business Overview
Table 89. CAHIC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 90. CAHIC Veterinary Vaccine Product Portfolio
Table 91. CAHIC Recent Development
Table 92. HVRI Company Information
Table 93. HVRI Business Overview
Table 94. HVRI Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 95. HVRI Veterinary Vaccine Product Portfolio
Table 96. HVRI Recent Development
Table 97. Ringpu Biology Company Information
Table 98. Ringpu Biology Business Overview
Table 99. Ringpu Biology Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 100. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 101. Ringpu Biology Recent Development
Table 102. Yebio Company Information
Table 103. Yebio Business Overview
Table 104. Yebio Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 105. Yebio Veterinary Vaccine Product Portfolio
Table 106. Yebio Recent Development
Table 107. DHN Company Information
Table 108. DHN Business Overview
Table 109. DHN Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 110. DHN Veterinary Vaccine Product Portfolio
Table 111. DHN Recent Development
Table 112. WINSUN Company Information
Table 113. WINSUN Business Overview
Table 114. WINSUN Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 115. WINSUN Veterinary Vaccine Product Portfolio
Table 116. WINSUN Recent Development
Table 117. Elanco Company Information
Table 118. Elanco Business Overview
Table 119. Elanco Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 120. Elanco Veterinary Vaccine Product Portfolio
Table 121. Elanco Recent Development
Table 122. Virbac Company Information
Table 123. Virbac Business Overview
Table 124. Virbac Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 125. Virbac Veterinary Vaccine Product Portfolio
Table 126. Virbac Recent Development
Table 127. Jinyu Bio-Technology Company Information
Table 128. Jinyu Bio-Technology Business Overview
Table 129. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 130. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 131. Jinyu Bio-Technology Recent Development
Table 132. ChengDu Tecbond Company Information
Table 133. ChengDu Tecbond Business Overview
Table 134. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 135. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 136. ChengDu Tecbond Recent Development
Table 137. CAVAC Company Information
Table 138. CAVAC Business Overview
Table 139. CAVAC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 140. CAVAC Veterinary Vaccine Product Portfolio
Table 141. CAVAC Recent Development
Table 142. Kyoto Biken Laboratories Company Information
Table 143. Kyoto Biken Laboratories Business Overview
Table 144. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 145. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 146. Kyoto Biken Laboratories Recent Development
Table 147. FATRO Company Information
Table 148. FATRO Business Overview
Table 149. FATRO Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 150. FATRO Veterinary Vaccine Product Portfolio
Table 151. FATRO Recent Development
Table 152. Vaksindo Company Information
Table 153. Vaksindo Business Overview
Table 154. Vaksindo Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 155. Vaksindo Veterinary Vaccine Product Portfolio
Table 156. Vaksindo Recent Development
Table 157. Bio-Labs Company Information
Table 158. Bio-Labs Business Overview
Table 159. Bio-Labs Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 160. Bio-Labs Veterinary Vaccine Product Portfolio
Table 161. Bio-Labs Recent Development
Table 162. Avimex Animal Health Company Information
Table 163. Avimex Animal Health Business Overview
Table 164. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 165. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 166. Avimex Animal Health Recent Development
Table 167. MEVAC Company Information
Table 168. MEVAC Business Overview
Table 169. MEVAC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 170. MEVAC Veterinary Vaccine Product Portfolio
Table 171. MEVAC Recent Development
Table 172. Biovac Company Information
Table 173. Biovac Business Overview
Table 174. Biovac Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 175. Biovac Veterinary Vaccine Product Portfolio
Table 176. Biovac Recent Development
Table 177. Atafen Company Information
Table 178. Atafen Business Overview
Table 179. Atafen Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 180. Atafen Veterinary Vaccine Product Portfolio
Table 181. Atafen Recent Development
Table 182. Dyntec Company Information
Table 183. Dyntec Business Overview
Table 184. Dyntec Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 185. Dyntec Veterinary Vaccine Product Portfolio
Table 186. Dyntec Recent Development
Table 187. BioTestLab Company Information
Table 188. BioTestLab Business Overview
Table 189. BioTestLab Veterinary Vaccine Sales (M Doses
